David M Nathan. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Comparative Effectiveness ResearchDiabetes Mellitus, Type 2/complicationsDiabetes Mellitus, Type 2/drug therapyExenatideHumansHypoglycemic Agents/administration & dosageHypoglycemic Agents/adverse effectsHypoglycemic Agents/therapeutic usePeptides/administration & dosagePeptides/adverse effectsPeptides/therapeutic useRandomized Controlled Trials as Topic/standardsResearch Design/standardsVenoms/administration & dosageVenoms/adverse effectsVenoms/therapeutic use
Substances: See more » Hypoglycemic AgentsPeptidesVenomsExenatide
Year: 2010 PMID: 21135287 DOI: 10.7326/0003-4819-154-2-201101180-00303
Source DB: PubMed Journal: Ann Intern Med ISSN: 0003-4819 Impact factor: 25.391